This site uses cookies to store information on your computer. I'm fine with this Cookie information
Follow is on Twitter Like us on Facebook Follow us on Instagram
Covid-19 (Coronavirus)

Information and guidance for public, NHSGGC staff, and community-based services.  Hospital visiting restrictions now in place.

NHS GG&C Research and Innovation

**************************************COVID-19 Update***************************************************

R&I have set-up a COVID-19 Taskforce Group (chaired by R&I Director). The purpose of this is to oversee and prioritise COVID-19 Clinical Trials and Research Data Collaborations for site permissions, set-up and delivery. 

COVID-19 clinical trials will be prioritised as follows:

  • Designated as Urgent Public Health Research
  • Have approval from national CSO/CMO
  • Adopted to NIHR Portfolio
  • Complementary rather than competitive to existing studies
  • Strong scientific rationale with evidence of likely benefit and low risk of harm **
  • Feasible within the limits of the reduced R&I workforce
  • Minimally burdensome to front-line clinical staff and all supportive services

** Assessed by Scientific Sub-committee for locally led projects (chaired by Prof Iain McInnes)

More information is available here

NHS GG&C R&I have established a COVID-19 Task force and Clinical Research Team to support recruitment and delivery of COVID-19 trials across NHS GG&C.

The aim is to ensure that NHS GG&C patients and clinicians have

  • access to the best possible experimental treatments and that this will lead to improved knowledge and availability of drugs that are proven to work to the wider population
  • increase our understanding of COVID-19 to help improve patient care and public health policy
  • increase are knowledge of the  genetic “make up” of the virus, so we can get better ways to detect, prevent and treat COVID-19

More information is available here

****************************************************************************************************************

Sufficient supply of the drug or other intervention has been confirmed to complete the trial (including confirmation of funding if not standard of care)The Research & Innovation service in NHS Greater Glasgow & Clyde operates to support researchers in the NHS and academia. It has multiple roles including offering consultancy and advice, providing Management Approval and aiding in the achievement of a successful conclusion to research projects. Our goal is to release the potential to world class clinical studies across the region, and to play our part in enabling Scotland to grow as an internationally competitive location for medical research.

The R&I management office acts as a catalyst for discovery and innovation within NHS GG&C. We have a ‘can-do’ attitude, striving to support both experienced and new researchers in the design and execution of high quality research studies and ensure compliance to all regulatory requirements.

As the busiest R&D office in Scotland, we received in excess of 690 new research applications in 2019 and have approximately 1000 studies ongoing at any one time. To ensure consistency of contact, and to help develop an in-depth understanding of therapy area-specific research projects, the NHS GG&C R&I Management office has adopted a ‘portfolio-team’ structure. The portfolio teams form the functional core of R&I and are comprised of Research Co-ordinators, Research Facilitators, Co-ordinator’s Assistants and clerical support staff.

 


 Clinical Innovation Strategy

The 5 core strategic objectives of the Research & Clinical Innovation Strategy are to:

  1. Deliver world leading quality research and innovation which will directly impact on and improve patient-centred care within Glasgow, Scotland and globally
  2. To fully embed a research and innovation culture within NHS GG&C
  3. Further promote patient and public engagement and participation in clinical research and innovation
  4. Optimise our use of informatics and real world data through collaboration regionally, Nationally and globally with NHS partners, industry and academia
  5. Actively support innovation and early adoption (or early rejection) of novel medicines and devices at scale, nationally and internationally

In order to achieve these objectives, NHS GG&C recognises:

  • The value of our strong academic partnership with University of Glasgow within the Glasgow Health Sciences Partnership (GHSP) and the important role of our clinical academics in delivering clinical research within NHS GG&C
  • Our close academic collaboration with Strathclyde University, Glasgow Caledonian, West of Scotland and Stirling University within the West of Scotland Health Sciences Network and others across Scotland & Nationally
  • The key role of research & innovation governance in ensuring that research and innovation areas conducted to high scientific, ethical & financial standards
  • The expanding role of our nurses, pharmacists, allied health professionals, translational scientists and associated academic partnerships in clinical research and as principal investigators
  • Our areas of current strength and research expertise
  • Our close collaboration with other boards both within the NHS Research West Node, the West of Scotland Health Sciences Network and other NHS boards across Scotland
  • Collaboration and close working with e-Health and Medical Physics within the West of Scotland
  • The value of existing and new key research partnerships through NHS research Scotland, local and national charities, trusts and voluntary organisations
  • The role of research and innovation to drive evidence based practice

The NHS Greater Glasgow & Clyde Research & Innovation Strategy document is available here.